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Received January 26, 1996 ; accepted June 6, 1996. low-density lipoprotein (LDL) receptor and the LDL receptorrelated protein [1] . The gene is located in chromosome 19 in a cluster with the apoC-I and C-I! genes. The apoE gene is polymorphic with three common codominant alleles (#{128}2, #{128}3, and #{128}4) encoding three plasma apoE isoforms (E2, E3, and E4, respectively).
These isoforms differ by amno acid substitutions at one or both of two sites (residues 112 and 158). The apoE3 isoform has cysteine at residue 112 and argimine at residue 158, whereas arginmne in apoE4 and cysteime in apoE2 are present at both sites [2] .
The study of the genetic variability at the apoE gene locus has aroused considerable interest in recent years. First, apoE isoforms have been shown to have a significant contribution to the variability in LDL cholesterol (LDL-C) concentrations in populations [3] . Second, subjects with the apoE4 allele appear to be at an increased risk of coronary heart disease (CHD) after adjusting for LDL-C concentrations, and this may also be the case for some apoE2 carriers [4] . Third, a significant association has been shown between the apoE4 allele, Alzheimer disease [5] , and dementia.
Moreover, apoE genetic variation may also explain some of the interindividual variability in plasma lipid response to dietary and drug therapies [6, 7] .
Traditionally, the characterization of the different apoE isoforms has been carried out by isoelectric focusing (JEF) with the VLDL fraction [8] or by IEF and immunoblotting of plasma or serum [9] . More recently the availability of techniques based on the polymerase chain reaction (PCR) permits the analysis of apoE variability at the gene level [10, 11] . Intralaboratory discrepancy between phenotype and genotype has been reported to vary between 0.2% and 24% [12-20], the latter being found in diabetic subjects [13, 14, 18] 
Subjects and Methods

SUBJECTS
In the present study we included a random subset of 1041 subjects (543 men and 498 women, age range 22 to 76 years, mean age 48 ± 10 years) enrolled in the Framngham Offspring Study. This cohort was initiated in 1971 with the intent to evaluate the role of genetic factors in the etiology of CHD [22] .
Informed consent was obtained from each participant in the study; all procedures followed were in accordance with the Helsinki Declarationof 1975, as revised in 1983. Offspring Cohort between 1983 and 1987. Plasma was immediately obtained by using low-speed ultracentrifugation, and 5 mL was subjected to ultracentrifugation in a Beckman 40.1 rotor at 115 000g for 18 h at4 #{176}C, ata densityof 1.006 kg/L. VLDL samples were obtained after tube slicing from the upper part of the centrifugetube, and the sample volume was brought to 2.5 mL. VLDL fractions were maintained at 4 #{176}C and transported on ice to the Lipid Metabolism laboratory in Boston within 24-48 h after their isolation. \TLDLs were dialyzed against bicarbonate, lyophilized, delipidated, and subjected to IEF within a pH range of 4.0 to 6.5. This procedure has been previously described in detail [8] . ApoE phenotypes were reassessed in a subset of the population during 1995 by IEF of whole plasma followed by immunoblotting. The plasma samples (1-mL aliquots) utilized for this purpose had been stored at -80 #{176}C since the time of their collection (1983) (1984) (1985) (1986) (1987) .
DNA ISOLATION AND APOE GENOTYPING
DNA was extracted from 5-mL blood aliquots collected during the fourth examination period of the Framingham Offspring Study (1987) (1988) (1989) (1990) (1991) by using a salting-out method [23] . Most DNA extractions were carried out within 2-4 days after blood collection. When the procedure could not be carried out within that period, the blood was frozen at -20 #{176}C and the DNA was extracted within the following 4-8 weeks.
ApoE genotyping was performed as described by Hixson and Vernier [10] . A 244-bp sequence of the apoE gene including the two polymorphic sites was amplified by PCR in a DNA Thermal Cycler (PTC-lOO; MJ Research, Watertown, MA) with oligonucleotide primers F4 (5'-ACAGAATFFCGCCCCGGCCTG-GTACAC-3') and F6 (5 '-TAAGCYFGGCACGGCTGTC-CAAGGA-3').
The and those determined after repeating the nonconcordant samples. In all cases, the phenotype and genotype distributions were in Hardy-Weinberg equilibrium. The data inTable 2 present a cross-tabulation of prevalence of genotype-phenotype discordancein the 32 subjectsin which the lack of concordance could not be resolved.The most common mismatches consisted of subjectstyped as E3/3 by phenotype but classified as E2/3 (n = 7) or E3/4 (n = 7) by genotype.
The average effect of #{128}2, #{128}3, and #{128}4 alleles on totalcholesterol, LDL-C, triglycerides, and HDL-C concentrations in the population and in the 32 subjects with genotype-phenotype discrepancies is shown in Tables 3 and 4 , respectively. In the whole group, no significant differences were found in the average effect of apoE alleles, obtained by genotype or phenotype, on plasma total cholesterol, LDL-C, and HDL-C. However, a significant difference (P <0.01) was noted in the average apoE allele effect on plasma triglycerides, calculated with the genotype or the phenotype assignments.
Similarfindings were noted regarding the effect of apoE locus-related variability on total cholesterol, LDL-C, triglycerides, and HDL-C in the 32 subjects with discrepancies.
The VLDL-C/triglycerides ratio was >0.3 in 14.4% of the subjects in the entire population. This percentage was significantly higher (28%) (P = 0.03) in the group with genotype-phenotype discrepancies.
Discussion
ApoE genetic variability has been traditionally determined by using IEF separation of VLDL proteins or whole plasma [8, 9] . Most recently, PCR has simplified the directassessment of the specific nucleotide mutations responsiblefor the common apoE isoforms [10] . Assuming that the most common mutations in the population are those at the 112 and 158 positions, one would expectcloseto complete concordance on the assessment of apoE variants with the two methodological approaches; however, several laboratories have reported a wide range of discrepancies between phenotype and genotype assessment (0.2-24%) [12] [13] [14] [15] [16] [17] [18] [19] [20] . The high rate of misclassification reported in some studies constitutes a major concern, given the large number of population studies reported in the literature and the important findings derived from their analyses.
The data obtained in the present study, the largest to date to compare apoE genetic variability by using IEF and PCR, agreed with previous reports on the presence of discrepancies between these two techniques.
Of 1041 subjects, 98 (9.4%) were appara Includes the 32 subjects presenting lack of concordance between phenotyping and genotyping. Nine studies have been reported that compared apoE phenotypes and genotypes [12] [13] [14] [15] [16] [17] [18] [19] [20] (Table 5 ). It should be noted that some of the studies with worse concordance were those with a high proportion of diabetics [13, 14, 18] , suggesting that the effect of posttranslational modification, mainly nonenzymatic glycation of apoE [26] , on isoform mobility may be of particular significance in diabetic patients; however, when Wenham et al. [14] compared the ratio of mismatches in two populations, insulin-dependent diabetics vs nondiabetic subjects, a greater discrepancy was observed among nondiabetics (17% vs 13%). Moreover, James et al. [19] only found one mismatch in 151 non-insulin-dependent diabetics (0.66%), suggesting that the differences in the IEF procedures may have been responsible for the differences within other studies in diabetics. The pretreatment of VLDL samples with neuraminidase does not seem to affect acidic isoforms of apoE in diabetics [13, 26] . The number of diabetic patients in our study population was insufficient (n = 32, 3.07%) to demonstrate whether diabetic status plays a significant role in phenotype interpretation. Stavljenic-Rukavina et al. [18] found a different number of mismatches depending on the genotyping method, being higher with allele-specific oligonucieotide probe (ASO) than with amplification refractory mutation system (ARMS). However, when PCR plus restriction isotyping was compared with singlestrand conformation polymorphism (SSCP) or with ASO, the agreement was complete [27, 28] . In this large population sample, no significant differences were found between allele distributions before and after correction of phenotype-genotype misassignments.
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Our results also suggest that apoE allele assignment by phenotype or genotype will yield similar allele frequency distributions, suggesting that the apoE allele frequencies previously reported in large population studies [29] may represent the true allele frequencies in the population, despite the probable occurrence of a certain number of misidentifications. More problematic may be the interpretation of the data presented in small population studies in which even a low number of misclassifications may significantly affect the final allele distribution.
One of the most important outcomes of previous population studies examining apoE isoforms has been the association between apoE alleles and LDL-C concentrations.
Our results indicate that similar lowering effects were associated with the apoE2 allele as determined by genotype or phenotype. This was also true regarding the raising effect associated with the apoE4 allele. Most intriguing was the significant difference found in the average effect of #{128}2 and #{128}4 alleles on triglyceride concentrations, depending on genotype or phenotype assignment. This feature could cast doubt on the effect of apoE alleles on triglyceride concentrations as determined only by phenotype, as previously reported [21, 30, 31] .
The multiple steps involved during genotyping or phenotyping may be the major source of misclassification.
Human errors Mailly et al. [15] 195 V-IEF+IB Tsukamoto et al. (16] 104 V-IEF+IB Tsaiet al. [17] 47 V-IEF+CBS Stavljenic-Rukavina et 50 V-IEF+CBS DID aI. [18] James et al. [19] 151 S-IEF+IB RI 0.6% DID NIDDM Hansen et al. (20] 460 P-IEF-IB Table 5 . Studies reported comparing apeE phenotypes and genotypes.
may occur at several points in this process and they apply to both PCR and IEF. These include labeling of the tubes, interpretation of hand-written numbers, transcription of the numbers to the assay tubes, placement of assay samples into gels, interpretation of the results, and introduction of the results in the database.
These problems have been previously reported in testing for Huntington disease [25] , and they underscore the importance of precise labeling, interpretation of the results by several investigators, and verification of data entry accuracy. Moreover, duplicate sampling should be carried out to reduce the need to obtain new samples later. Additional sources of error are associated specifically with each of these techniques.
Thus, genotyping assessment may be affected by the quality of the DNA, especially when high-throughput methods are being used [32] . Poor amplification may result in bands with very low intensity or artifactual bands. This is especially important for apoE restriction isotyping [10] , due to the low-molecular-mass bands used to identify the apoE2/3 and especially the apoE2/2 genotypes; however, this can also affect the interpretation of the apoE4 allele. Several other PCR-based methods have been successfully adapted to the study of apoE mutations [13, 17, 18] .
In the case of phenotyping by IEF, the technical problems will be different for IEF of VLDL and protein staining or total plasma and immunoblotting.
In the first case, VLDL should be isolated as soon as possible from fresh plasma. In our experience, if VLDL is not used within 2 days of its isolation, the IEF profile presents an enrichment of E2-like bands. Furthermore, samples with very low triglyceride concentrations, and consequently low VLDL concentrations, did not provide enough material to carry out successful staining, especially when minigels were used, due to the limited loading capacity of these gels. Interpretation of the IEF gels may also be affected by the presence of other proteins within the same isoelectric point range that could be misinterpreted as apoE isoforms. Finally, a different distribution of apoE isoforms has been described between the VLDL and HDL fractions. This property of the isoforms may alsoaffect the phenotype interpretation when VLDL is used.
Direct phenotype assessment with whole plasma and specific antibodiesavoidsmany of these problems, and several variants of this technique have been recentlypublished [33] [34] [35] . By using whole plasma, no bias is introduced because of the different distribution of apoE between lipoprotein fractions, and the problem associated with low \TLDL samples is eliminated. Furthermore, the specificity obtained by immunostaining avoids the problem associated with other proteins focusing within the same range.However, the antibody should be tested to ensure similar reactivity with all different isoforms.
Some discrepancies that remain after careful assessment of the technicalerrorsmay be due to true rare genetic mutations. Over 20 rare apoE alleles have been detected by either genotyping or phenotyping [36, 37] . Although phenotyping may detect most of these mutations,only the careful selection of PCR primers, specific probes,or directsequencing permits the identification of these mutations with DNA analysis. As a first step to investigate this possibility, we examined the lipid profile of the 32 subjects for which the lack of discrepancy remained after verification of phenotype and genotype. When the apoE allele-associated effect on plasma lipid concentrations was examined in these subjects, we found that the genotype assignment followed the normal trend; i.e., LDL-C concentrations were lower in E2 subjects and greater in E4 subjects. However, when the same calculations were carried out on the basis of the phenotype assignment, a different picture emerged. The apoE2 allele was associated with higher LDL-C and triglyceride concentrations.
In the case of the apoE4 allele a somewhat reduced hypercholesterolemic effect was noted and a significant triglyc-discrepancies eride lowering effect was noted. Furthermore, the VLDL-C/ triglyceride ratio in nine of these subjects was >0.3, although none of them was classified as an E2/2 by either phenotype or genotype.
This data suggests that a large proportion of these subjects (28%) had a lipoprotein profile consistent with -dyslipoproteinemia.
This percentage was significantly higher than that observed for the entire population (14.4%) (P = 0.03). These findings suggest that other rare apoE mutations may be present in this population and may be an important determinant of lipid disorders, as we have recently shown in a different population [38] .
In conclusion, at the population level, both apoE typing methods resulted in similar apoE allele frequencies and allelic effects on total cholesterol, LDL-C, and HDL 
